| 产品详情 |
| Edit |   |
|---|
| Product Name | Glucagon-Like Peptide 1 Receptor Agonist |
|---|
| Description | Purity ~97% (HPLC). A nonpeptidic quinoxaline compound that acts as a GLP-1R agonist and an allosteric modulator of GLP-1 binding. Shown to induce GLP-1R-mediated cAMP production in BHK plasma membrane preparations (EC50=101nM) and potentiate glucose-dependent insulin release in pancreatic islets derived from wild-type, but not GLP-1R -/-, mice. Unlike GLP-1, its biological activity is not inhibited by orthosteric antagonists such as Exendin. Formula: C13H15Cl2N3O2S Solubility: DMSO (20mg/ml), Ethanol (10mg/ml) Molecular Weight: 348.3 |
|---|
| Size | 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Glucagon-Like Peptide 1 Receptor Agonist (6,7-Dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline, GLP-1R Agonist) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 217385 |
|---|
| Price | |
|---|
| Order / More Info | Glucagon-Like Peptide 1 Receptor Agonist from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|